A detailed history of Ameritas Investment Partners, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 12,670 shares of JAZZ stock, worth $1.56 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
12,670
Previous 13,409 5.51%
Holding current value
$1.56 Million
Previous $1.43 Million 1.33%
% of portfolio
0.05%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.57 - $116.37 $74,321 - $85,997
-739 Reduced 5.51%
12,670 $1.41 Million
Q2 2024

Aug 13, 2024

SELL
$103.94 - $118.98 $51,138 - $58,538
-492 Reduced 3.54%
13,409 $1.43 Million
Q4 2023

Feb 14, 2024

SELL
$114.26 - $136.0 $29,593 - $35,224
-259 Reduced 1.83%
13,901 $1.71 Million
Q3 2023

Nov 13, 2023

SELL
$122.0 - $145.31 $228,140 - $271,729
-1,870 Reduced 11.67%
14,160 $1.83 Million
Q1 2023

May 10, 2023

SELL
$133.98 - $160.47 $35,638 - $42,685
-266 Reduced 1.63%
16,030 $2.35 Million
Q4 2022

Feb 13, 2023

BUY
$129.72 - $159.85 $22,830 - $28,133
176 Added 1.09%
16,296 $2.6 Million
Q3 2022

Nov 14, 2022

SELL
$126.59 - $161.18 $63,295 - $80,590
-500 Reduced 3.01%
16,120 $2.15 Million
Q2 2022

Aug 12, 2022

BUY
$141.59 - $168.66 $26,052 - $31,033
184 Added 1.12%
16,620 $2.59 Million
Q4 2021

Feb 11, 2022

BUY
$119.87 - $145.67 $23,015 - $27,968
192 Added 1.18%
16,436 $2.09 Million
Q2 2021

Aug 06, 2021

BUY
$160.2 - $186.42 $119,509 - $139,069
746 Added 4.81%
16,244 $2.89 Million
Q1 2021

May 14, 2021

BUY
$150.19 - $173.5 $15,019 - $17,350
100 Added 0.65%
15,498 $2.55 Million
Q4 2020

Feb 12, 2021

SELL
$140.71 - $165.05 $42,635 - $50,010
-303 Reduced 1.93%
15,398 $2.54 Million
Q3 2020

Nov 13, 2020

BUY
$105.46 - $144.13 $1.66 Million - $2.26 Million
15,701 New
15,701 $2.24 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.